Labcorp Holdings Inc. (LH) vs Revvity Inc. (RVTY)

Labcorp Holdings Inc. and Revvity Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $29.5B against $16.8B — 1.8× the size. Labcorp Holdings Inc. trades at the lower P/E: 29.5× against 71.9×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.02% against 4.56%. Revvity Inc. has the higher net margin (8.61% vs 6.88%) and the lower return on invested capital (2.50% vs 6.76%). Both pay a dividend; Labcorp Holdings Inc. yields more (0.79% vs 0.19%). Across the 23 metrics below, Labcorp Holdings Inc. leads on 15 and Revvity Inc. on 8.

Valuation

Metric LH RVTY Diagnostics & Research median
P/E 29.53 71.89 34.52
P/S 2.01 5.73 4.24
P/B 3.32 2.33 3.42
Price to free cash flow 25.40 28.19 33.51
EV/EBITDA 15.61 25.08 23.44
EV/Sales 2.36 6.61 5.18
Earnings yield 3.39% 1.39% (1.50%)
Free cash flow yield 3.94% 3.55% 0.00%

Profitability

Metric LH RVTY Diagnostics & Research median
Gross margin 28.96% 55.91% 48.32%
Operating margin 10.29% 12.65% (5.68%)
Net margin 6.88% 8.61% (4.10%)
Free cash flow margin 8.87% 20.48% 0.00%
Return on equity 11.45% 0.00% 0.00%
Return on assets 5.40% 2.14% (6.05%)
Return on invested capital 6.76% 2.50% 0.00%

Growth

Metric LH RVTY Diagnostics & Research median
Revenue growth (TTM) 6.02% 4.56% 8.99%
EPS growth (last fiscal year) 18.33% (5.91%) 20.36%
Revenue growth, 5-year CAGR (0.04%) 1.41% 7.30%
Net income growth, 5-year CAGR (10.85%) (19.82%) 0.00%

Health

Metric LH RVTY Diagnostics & Research median
Debt to equity 0.60 0.36 0.01
Current ratio 1.41 2.65 2.27
Net debt to EBITDA 2.23 3.00 0.68

Dividend

Metric LH RVTY Diagnostics & Research median
Dividend yield 0.79% 0.19% 0.67%
Payout ratio 0.24 0.12 0.20

Size

Metric LH RVTY Diagnostics & Research median
Market cap 29.50b 16.83b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack